Guangzheng Eye Hospital GroupLtd 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Yonglin Zhou

최고 경영자

CN¥1.3m

총 보상

CEO 급여 비율	n/a
CEO 임기	16.4yrs
CEO 소유권	0.05%
경영진 평균 재임 기간	2yrs
이사회 평균 재임 기간	4.7yrs

최근 관리 업데이트

Recent updates

Revenues Not Telling The Story For Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) After Shares Rise 28%

Nov 13

Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Jun 06

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares Climb 26% But Its Business Is Yet to Catch Up

Mar 18

CEO

Yonglin Zhou (58 yo)

16.4yrs

테뉴어

CN¥1,271,100

보상

Mr. Yonglin Zhou is Chairman and General Manager of Guangzheng Eye Hospital Group Co., Ltd and has been its Director since June 25, 2008.

리더십 팀

이름	위치	테뉴어	보상	소유권
Yonglin Zhou	Chairman & GM	no data	CN¥1.27m	0.053% CN¥ 1.1m
Li Junying	CFO & Director	13.1yrs	CN¥828.60k	0.078% CN¥ 1.6m
Jianmin Wang	Deputy GM & Director	no data	CN¥988.80k	0.068% CN¥ 1.4m
Tiejun Wang	Deputy GM & Non-Independent Director	6.3yrs	CN¥966.10k	0.097% CN¥ 2.0m
Wenling Wang	Chief Economist	2yrs	CN¥587.70k	0.0023% CN¥ 47.0k
Zhifang Chen	Deputy General Manager	1.7yrs	CN¥906.70k	0.037% CN¥ 763.7k
Qi Wang	Accounting Supervisor	no data	데이터 없음	데이터 없음
Wei Li	Secretary	2yrs	데이터 없음	데이터 없음

2.0yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: 002524 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yonglin Zhou	Chairman & GM	16.4yrs	CN¥1.27m	0.053% CN¥ 1.1m
Li Junying	CFO & Director	3yrs	CN¥828.60k	0.078% CN¥ 1.6m
Jianmin Wang	Deputy GM & Director	6.4yrs	CN¥988.80k	0.068% CN¥ 1.4m
Tiejun Wang	Deputy GM & Non-Independent Director	3yrs	CN¥966.10k	0.097% CN¥ 2.0m
Xin Feng	Non-Independent Director	16.4yrs	CN¥10.00k	데이터 없음
Yong Wang	Non-Independent Director	16.4yrs	CN¥10.00k	데이터 없음
Hongxin Yang	Chairman of the Supervisory Board	6.4yrs	데이터 없음	0.0040% CN¥ 82.3k
Yitao Song	Non-Employee Supervisor	3yrs	데이터 없음	데이터 없음
Aimin Yan	Independent Director	3yrs	CN¥120.00k	데이터 없음
Jian Ge	Independent Director	3yrs	CN¥120.00k	데이터 없음
Shiqiao Zheng	Independent Director	3yrs	CN¥120.00k	데이터 없음
Weili Li	Supervisor	6.4yrs	데이터 없음	0.0024% CN¥ 49.9k

4.7yrs

평균 재임 기간

55.5yo

평균 연령

경험이 풍부한 이사회: 002524 의 이사회는 경험(평균 재직 기간 4.7 년)으로 간주됩니다.

Guangzheng Eye Hospital GroupLtd 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Guangzheng Eye Hospital Group Co.,Ltd., Annual General Meeting, May 20, 2024

High number of new directors

High number of new directors

Guangzheng Eye Hospital Group Co., Ltd., Annual General Meeting, May 20, 2022

Recent updates

Revenues Not Telling The Story For Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) After Shares Rise 28%

Third quarter 2024 earnings released

Guangzheng Eye Hospital Group Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released

Guangzheng Eye Hospital Group Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

First quarter 2024 earnings released: CN¥0.04 loss per share (vs CN¥0.02 loss in 1Q 2023)

Guangzheng Eye Hospital Group Co.,Ltd., Annual General Meeting, May 20, 2024

Guangzheng Eye Hospital Group Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares Climb 26% But Its Business Is Yet to Catch Up

Guangzheng Eye Hospital Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.42 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.02 (vs CN¥0.051 loss in 2Q 2022)

New major risk - Revenue and earnings growth

First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.07 loss in 1Q 2022)

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 21% undervalued

High number of new directors

Now 21% undervalued

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.42 (vs CN¥0.03 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.051 loss per share (vs CN¥0.04 profit in 2Q 2021)

Full year 2021 earnings released: EPS: CN¥0.085 (vs CN¥0.085 in FY 2020)

High number of new directors

Guangzheng Eye Hospital Group Co., Ltd., Annual General Meeting, May 20, 2022

Full year 2021 earnings released: EPS: CN¥0.09 (vs CN¥0.085 in FY 2020)

Fujian Shencheng Energy Trade Co., Ltd entered into share transfer letter of intent to acquire 10% stake in Toksun Xin Tianshan Natural Gas Co., Ltd. from Guangzheng Eye Hospital Group Co., Ltd. (SZSE:002524) CNY 72 million.

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: CN¥0.03 loss per share (vs CN¥0.08 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.056 loss in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.08 (vs CN¥0.14 in FY 2019)

New 90-day low: CN¥10.03

New 90-day low: CN¥10.61

New 90-day low: CN¥11.46

New 90-day high: CN¥13.40

Guangzheng Group Co.,Ltd to Report Q3, 2020 Results on Oct 23, 2020

New 90-day high - CN¥13.28

Guangzheng Group Co.,Ltd to Report First Half, 2020 Results on Aug 25, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령